Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
about
"Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children.Immunotherapy in allergy and cellular tests: state of art.Road map for the clinical application of the basophil activation test in food allergy.Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.FceRI density and spontaneous secretion from human basophils.Stability of Syk protein and mRNA in human peripheral blood basophils.Immunotherapy of Food Allergy: a Comprehensive Review.Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.Cashew allergy, 2S albumins, and risk predictions based on IgE antibody levels.
P2860
Q34647874-E7FBC716-DC51-416B-8879-8CB69666D634Q34782224-E210322B-F1D1-4C09-B26C-9A55CC407A1BQ36919753-3964A75D-B590-47D7-8A90-57932691B46FQ37694934-04133BFD-1BD6-4ECF-99C7-4D5EC196F634Q38203380-8C7DE490-0743-40A1-BB38-A8D99AD86BF2Q38724206-FF58D134-7109-4201-A7F3-3464D1BED6E0Q39012896-C6C31A89-2C32-4DCD-B4C5-B3A3E83C5CF0Q40249043-8CE65AF3-6963-464D-81B5-F4CB2E6603EDQ40975874-7F28BE2C-66AC-4A8D-84BE-1DD67AC664B7Q42360949-19461E5C-AF05-4375-9238-B0C69D8F24E2Q46222311-97450497-7491-464B-811A-906259332BE9Q47203998-E1C11DD4-6BBD-4574-9F3A-A55B683C31E7Q48256384-8E03AB40-63BF-4034-875E-0E08622E5C52Q51320544-E1A5BA62-C12A-48E0-AA5D-EA70F023A400
P2860
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@ast
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@en
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@nl
type
label
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@ast
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@en
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@nl
prefLabel
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@ast
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@en
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@nl
P2860
P1476
Omalizumab increases the intri ...... s to IgE-mediated stimulation.
@en
P2093
Donald W Macglashan
Sarbjit S Saini
P2860
P304
906-11.e1-4
P356
10.1016/J.JACI.2013.04.056
P407
P577
2013-06-20T00:00:00Z